What are the treatment options for fungal nail infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Fungal Nail Infections

Oral terbinafine is the first-line treatment for fungal nail infections (onychomycosis) with 70-80% efficacy for toenails and 80-90% for fingernails. 1

Diagnosis Confirmation

  • Diagnosis should be confirmed through:
    • Microscopic examination with potassium hydroxide (KOH)
    • Mycological culture
    • Nail biopsy in doubtful cases
  • Important: Only approximately 50% of nail dystrophies are actually caused by fungi 1

Treatment Algorithm

First-line treatments:

  1. For single nail infection:

    • Topical antifungal: Amorolfine 5% nail lacquer applied once or twice weekly for 6-12 months (50% efficacy) 1
  2. For multiple nail infections or severe cases:

    • Oral terbinafine: 250mg once daily for 6 weeks (fingernails) or 12 weeks (toenails) 2
      • Highest efficacy: 73-94% mycological cure rate 1
      • Preferred for dermatophyte infections 1

Alternative oral treatments:

  1. Itraconazole:

    • 200mg daily for 12 weeks (continuous therapy) 1
    • OR 200mg twice daily for 1 week per month × 2-3 pulses (pulse therapy) 1
    • Particularly effective for Candida onychomycosis (92% cure rate with pulse therapy) 1
    • High-quality evidence shows terbinafine is more effective than azoles like itraconazole 3
  2. Fluconazole:

    • 450mg once weekly for 3 months (fingernails) or at least 6 months (toenails) 4
    • Useful alternative when patients cannot tolerate terbinafine or itraconazole 4
    • Once-weekly dosing may improve compliance 4

Alternative topical treatments:

  • Ciclopirox 8% lacquer (34% mycological cure rate) 1
  • Efinaconazole 10% solution (50% mycological cure rate) 1
  • Tioconazole 28% solution (contraindicated in pregnancy) 1

Special Considerations

By Pathogen Type:

  • Dermatophytes: Terbinafine preferred (highest efficacy) 1
  • Candida species: Itraconazole is particularly effective 1, though terbinafine has also shown efficacy 5
  • Non-dermatophyte molds: Itraconazole has shown effectiveness (88% cure rate) 6
  • Mixed infections: Itraconazole effective (84% clinical cure, 68% mycological cure) 6

Special Populations:

  • HIV patients: Terbinafine and fluconazole preferred (fewer interactions with antiretrovirals) 1
  • Diabetic patients: Terbinafine preferred (fewer drug interactions) 1
  • Pediatric patients: Terbinafine dosing varies by weight:
    • <20kg: 62.5mg daily
    • 20-40kg: 125mg daily
    • 40kg: 250mg daily 1

Common Adverse Effects

Terbinafine:

  • Gastrointestinal symptoms
  • Headache
  • Taste disturbance (may become permanent)
  • Liver problems (rare but serious) 2

Itraconazole:

  • Headache
  • Gastrointestinal complaints
  • More drug interactions than terbinafine 4

Fluconazole:

  • Headache
  • Skin rash
  • Gastrointestinal complaints
  • Insomnia 4

Prevention of Recurrence

  • Keep nails short and clean
  • Dry feet thoroughly after bathing
  • Wear cotton, absorbent socks and change daily
  • Apply antifungal powders to shoes and feet
  • Avoid sharing nail clippers
  • Wear protective footwear in public areas
  • Treat concomitant fungal infections promptly 1

Treatment Failure Management

  • Partial nail removal plus antifungal therapy
  • Alternative antifungal drug
  • Complete nail avulsion combined with antifungal therapy 1

Common Pitfalls to Avoid

  • Not confirming diagnosis before starting treatment
  • Inadequate treatment duration
  • Simultaneous use of corticosteroids with antifungals
  • Unrealistic expectations about improvement speed
  • Not addressing predisposing factors
  • Not implementing preventive measures 1

References

Guideline

Fungal Nail Infection Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral antifungal medication for toenail onychomycosis.

The Cochrane database of systematic reviews, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Candida nail infection with terbinafine.

Journal of the American Academy of Dermatology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.